Pre clinical study |
MCT rats |
EPC |
Intravenous |
↓connexin43, eNOS expression, ↑ alveolar sacs, ↑ small lung arterioles |
Indirect. ↓RVSP, ↓ RVH, ↓ connexin43, eNOS expression |
In pulmonary arterioles |
No |
Yip et al., 2008 |
|
|
|
↑ n small lung arterioles, ↓ pulmonary arteriole muscularization |
Indirect. ↓RVSP, ↓ RVH |
In small pulmonary arterioles |
No |
Xia et al., 2009 |
|
|
|
↓ pulmonary arteriole muscularization |
Indirect. ↓RVSP, ↓ RVH |
In lung tissue after 15 min but not 24h after injection |
No |
Ormiston et al., 2009 |
|
|
|
ø |
ø |
ø |
No |
Mirsky et al., 2011 |
|
EPC producing prostacyclin |
Intravenous |
↓ pulmonary vessel wall thickening, ↓ cell proliferation in pulmonary vessel wall |
Indirect. ↓RVSP, ↓ RVH |
In lungs up to 25 days |
No |
Zhou et al., 2013 |
|
eNOS transduced EPC |
Intravenous |
↓ pulmonary arteriole muscularization, ↑ microvascular perfusion |
Indirect. ↓RVSP, ↓ RVH |
In distal arterioles |
No |
Zhao et al., 2005 |
|
EPC + sildenafil |
Intravenous |
↑ alveolar sacs, ↑ small lung arterioles, ↓ apoptic and inflammatory biomarkers |
Indirect. ↓ apoptic and inflammatory biomarkers, ↓RVSP, ↓ RV weigh |
ø |
No |
Yen et al., 2013 |
|
EPC + cilostazol |
Intravenous |
↑ alveolar sacs, ↑ small lung arterioles |
Indirect. ↓ connexin43, eNOS expression, ↓RVSP, ↓ RV weigh |
In pulmonary arterioles |
No |
Sun et al., 2009 |
|
MSC |
Intravenous |
↓ thickening of arterioles and alveolar septa |
Indirect. ↓RVDP, ↓ RVH, ↓ RVEF |
ø |
No |
Umar et al., 2009 |
|
|
|
↓ media wall thickness, ↓ intra-acinar muscular pulmonary arteries |
Indirect. ↓ RVP, ↓ RVH, ↓ mRVP |
Lung tissue |
No |
Lee et al., 2015 |
|
|
|
↓ media wall thickness, ↑ capillary density |
Indirect. ↓RVSP, ↓RVH |
Pulmonary vessels |
No |
Yuelin Zhang et al., 2012 |
|
|
Intratracheal |
↓PAP, ↓PVR |
Indirect. ↓ RVH |
Lung |
No |
Baber et al., 2006 |
|
MSC primed with S1P |
Intravenous |
↓ pulmonary vascular wall thickness, ↑ capillary density |
Indirect. ↓RVSP, ↓ RV/(LV+S) |
ø |
No |
Kang et al., 2015 |
|
MSC expressing Heme Oxygenase-1 |
Intravenous |
↓ media wall thickness, ↓ inflammation |
Indirect. ↓RVSP, ↓ RVH |
Lung |
No |
Liang et al., 2010 |
|
MSC overexpressing eNOS |
Intravenous |
ø |
Direct. ↓RVSP, ↓ RV weight/body weight |
ø |
No |
Kanki Horimoto et al., 2006 |
|
ADSC |
Intravenous |
↓mPAP, ↓wall/lumen thickness, ↓wall/lumen area |
Indirect. ↓RVH |
Lung tissue |
No |
Luo et al., 2014 |
|
ADSC expressing COX-1 |
Intratracheal |
↓mPAP, ↓ vascular remodeling |
Indirect. ↓RVH, ↓RV mass |
Lung parenchyma |
No |
Somanna et al., 2014 |
|
iPS cells |
Intravenous |
↓wall/lumen thickness, ↓lung tissue inflammation (IL-1β, IL-6, IL-12, IL-23, IFNγ) |
Direct. ↓RVH,↓RVSP |
Lung parenchyma |
No |
Huang et al., 2016 |
Left to right shunt rat |
MSC |
Intravenous |
↓mPAP, ↓ media thickness, ↓ intima thickness, ↓ pulmonary arteries luminal area, ↓ inflammation factors |
Indirect. ↓RV/(LV+S), ↓RVSP, ↓mRVP, ↓RV/body weight |
ø |
No |
Luan et al. |
LV pressure overload with biventricular failure in rat |
MSC |
Intracoronary |
ø |
Direct. ↓RVSP, ↓RVDP, ↓ inflammation, apoptosis and ECM remodeling markers |
ø |
No |
Molina et al., 2008 |
RV volume overload piglet |
CPC |
Epicardial |
ø |
Direct. ↓ in peri-myocytes fibrosis, protection against arrhythmia |
No cell survival in RV at 3 months |
No |
Lambert et al., 2015 |
RV volume overload sheep |
MNC |
Epicardial |
ø |
Direct. Improved RV diastolic function under dobutamine stress, ↑ capillary density |
ø |
No |
Yerebakan et al., 2009 |